Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials.
Heart failure is an important cause of morbidity and mortality. Clinical trials over the past 2 decades have revolutionized the care of patients with systolic heart failure, and substantial data support the use of angiotensin-converting enzyme inhibitors, beta-blockers, angiotensin-receptor blockers, and aldosterone blockers in the management of this serious condition. This article reviews the evidence on the pharmacologic treatment of heart failure, with a focus on recent clinical trials.
Yan
Andrew T
AT
St. Michael's Hospital, the Heart & Stroke/Richard Lewar Centre of Excellence, and Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Yan
Raymond T
RT
Liu
Peter P
PP
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D002317:Cardiovascular Agents